Why is Core Scientific stock up 3.7% today?

Traders Union
All News
Stocks
Core scientific rises 3.71% today

Highlights

DSC Meridian Capital LP invested approximately $48,755,000 in Core Scientific by purchasing 1,905,252 shares.
Core Scientific reported quarterly revenue of $164.2 million and a net loss per share of $3.32, missing analyst expectations.
Shares of Core Scientific trade below key moving averages with technical signals indicating oversold conditions and a likely range of $16.81 to $19 over the next five days.

Large stake and earnings miss drive mixed investor sentiment

DSC Meridian Capital LP has acquired 1,905,252 shares of Core Scientific, Inc., representing an investment of approximately $48,755,000. The company recently reported a quarterly revenue of $164.20 million and a net loss per share of $3.32, which missed analyst expectations. As of the latest update, Core Scientific's market capitalization is about $5.55 billion.

Anton Kharitonov, expert at Traders Union, sees Core Scientific under clear technical and fundamental pressure. The recent stake by DSC Meridian Capital has triggered only a brief bounce, with the stock still locked below key moving averages. Technical indicators, including an RSI below 35 and a negative Bull/Bear Power, confirm a persistent sell bias. Weak quarterly results and a large net loss per share further erode investor confidence. "Traders should remain cautious as downward momentum and challenging fundamentals limit near-term upside."

Viktoras Karapetjanc, expert at Traders Union, highlights the significance of institutional interest from DSC Meridian Capital. He believes that large-scale investments often precede structural shifts, even as current technicals appear weak. Karapetjanc maintains that Core Scientific's sector positioning and market cap support potential for a rebound. "The bullish structure remains intact — further growth is possible if resistance is crossed and renewed confidence translates into broader accumulation."

Sholanke Dele, market strategist, finds the sentiment turn after DSC Meridian’s involvement shallow and short-lived. He points to weak price action and heavy selling pressure as signs that investors doubt sustainability. Dele notes that volatility remains high while bearish signals dominate the outlook. "Without a decisive catalyst, I see more downside risk ahead for Core Scientific in the near term."

Technical barriers remain as bearish momentum dominates signals

Core Scientific remains under pressure, trading below its 20-day ($20.10), 50-day ($22.85), and 200-day ($19.72) moving averages. Near-term resistance is set at $19, with immediate support at $17.79, today's high. Momentum indicators show continued weakness: the MACD and ADX both indicate a sell bias. The RSI is at 34.62, the CCI at -164.91, and the Stochastic RSI at 0, all signaling oversold conditions. The Bull/Bear Power at -1.51 and the Awesome Oscillator also point to sustained bearish momentum. Despite today's upside gap and move toward the top of the daily range, heavy selling in momentum signals weak follow-through potential.

Previously it was reported that Core Scientific faced sustained selling pressure and elevated financial risks, highlighting a cautious outlook despite significant contract wins. The current analysis confirms this cautious stance, with momentum signals and key technical levels indicating that traders should monitor the $19 resistance and $17.79 support for any shift in the prevailing downside risk scenario.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.